Multimodality therapy for esophageal cancer

Chest

Volumn 112, Issue 4 SUPPL., 1997, Pages 195S-200S

  Forastiere, Arlene A ^a   Heitmiller, Richard F ^a   Kleinberg, Lawrence ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; MITOMYCIN;

CANCER CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CONFERENCE PAPER; ESOPHAGUS CANCER; METASTASIS; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TREATMENT PLANNING;

EID: 0030804662     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.112.4_Supplement.195S     Document Type: Conference Paper

References (7)

1. Roth JA, Putnam JB Jr, Rich TA, et al. Cancer of the esophagus. In: DeVita VT Jr, Hellman S, Rosenberg SA, eds. Cancer principles and practice of oncology. Philadelphia: Lippincott, 1996; 980-1054
2. Blot WJ, Devesa SS, Kneller RW, et al. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991; 265:1287-89
3. Macfarlane GJ, Boyle P. The epidemiology of oesophageal cancer in the UK and other European countries. J Soc Med 1994; 87:334-37
4. Heitmiller RF, Sharma RR. Comparison of prevalence and resection rates in patients with esophageal squamous cell carcinoma and adenocarcinoma. J Thorac Cardiovasc Surg 1996; 112:130-36
5. Fink U, Stein HJ, Bochtler H, et al. Neoadjuvant therapy for squamous cell esophageal carcinoma. Ann Oncol 1994; 5:S17-S26
6. Ilson DH, Kelsen DP. Combined modality therapy in the treatment of esophageal cancer. Semin Oncol 1994; 21: 493-507
7. Forastiere AA, Urba SG. Combineel modality therapy for cancer of the esophagus. PPO Updates 1996; 10:1-15